Urichofeb

Urichofeb (Febuxostat) is an oral medication used to manage uric acid levels in the body. It supports gout and hyperuricemia treatment by reducing uric acid production. This non-purine xanthine oxidase inhibitor is prescribed for adults. Always follow healthcare guidance when using this medication.

Febuxostat is primarily used to treat gout and hyperuricemia, conditions caused by high uric acid levels in the blood. It helps prevent gout attacks by lowering uric acid production. People with chronic kidney disease or those who cannot tolerate allopurinol may be prescribed febuxostat. It is not a pain reliever but helps manage the underlying condition.

Febuxostat works by blocking an enzyme that produces uric acid, which can help reduce the frequency of gout attacks over time. Some users may experience mild side effects such as nausea, joint pain, or liver enzyme changes. These effects vary by individual and should be monitored by a healthcare provider.

Before taking febuxostat, inform your doctor about any liver or kidney conditions, heart disease, or allergies. Regular blood tests may be needed to check uric acid levels and liver function. Keep this medication out of reach of children and store it at room temperature in a dry place.

Febuxostat may interact with medications that affect liver enzymes, such as azathioprine or mercaptopurine. Combining it with certain diuretics or chemotherapy drugs could increase uric acid levels. Alcohol and high-purine foods may reduce its effectiveness. Always consult a healthcare provider before mixing medications.